Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.
The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.
The Swedish imaging IT and cybersecurity company best known as a highly rated PACS supplier has retooled its enterprise imaging platform to incorporate genomics data.
Last week CMS dug in with its decision to put off finalizing an alternative value-based payment model for radiation oncology services to “a date to be determined through future rulemaking.”
"We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," says Moderna CEO Stéphane Bancel.
Children’s Hospital New Orleans is tapping Cleveland Clinic as a way to make sure Pelican State families have ready access to board-certified pediatric radiologists.
United Imaging Healthcare of Shanghai just became the seventh Chinese company this year to enjoy an IPO topping $1 billion—and the third best-performing of the bunch.